Uetersen, Germany

Silke Huettler

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nordmark Arzneimittel Gmbh & Co. Kg. Active years: 2013-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Silke Huettler. Retrieved from https://idiyas.com/inventor/silke-huettler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0



Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Silke Huettler: Innovator in Tissue Dissociation Technologies

Introduction

Silke Huettler is a notable inventor based in Uetersen, Germany. She has made significant contributions to the field of tissue dissociation through her innovative patents. With a total of 2 patents, her work focuses on enhancing the efficiency and effectiveness of cell isolation techniques.

Latest Patents

Silke's latest patents include the development of a neutral protease (NP) and a product utilizing this enzyme for tissue dissociation. The method involves mixing a neutral protease, which is not part of a collagenase enzyme preparation and is not produced through recombinant methods, with collagenase prior to tissue dissociation. This combination aims to improve the isolation results concerning yield, viability, and integrity of the cells.

Career Highlights

Silke Huettler is associated with Nordmark Arzneimittel GmbH & Co. KG, where she applies her expertise in enzyme technology. Her innovative approaches have positioned her as a key figure in the development of advanced tissue dissociation methods.

Collaborations

Silke has collaborated with notable colleagues, including Christian Raemsch and Nicole Raemsch-Guenther, who contribute to her research and development efforts.

Conclusion

Silke Huettler's work in the field of tissue dissociation represents a significant advancement in biotechnology. Her innovative patents and collaborative efforts continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…